# Vygon signs exclusive agreement with Carmat for artificial heart vascular graft

Vygon has signed an exclusive agreement with Carmat to develop a new vascular graft for the Aeson artificial heart, the world's first highly hemocompatible, pulsatile and self-regulating bioprosthetic artificial heart.

- Type: Partnership
- Announced: 2023-06-21
- Where: France
- Status: announced
- Products: vascular graft for artificial heart, Aeson artificial heart
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Vygon Group](https://endata.com/companies/43920.md) (partner)
- [Carmat](https://endata.com/companies/70974.md) (partner)

## Sources

- [us.vygon.com](https://us.vygon.com/en/news/vygon-signs-exclusive-agreement-carmat-french-manufacturer-orthotopic-artificial-heart), 2023-06-21: "We are honored that Carmat has chosen us to develop this new vascular graft, the first of its kind in the world."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.